Join GenScript’s First Gene & Cell Engineering Virtual Summit

Facebooktwitterredditpinterestlinkedinmail

GenScript, the leading contract research organization in the world providing gene, peptide, protein, CRISPR, and antibody, will host the first GenScript Gene & Cell Engineering Virtual Summit, July 22, 2021, opening at 11:00 AM EDT.

Gene and cell engineering advances have influenced almost all branches of life sciences. From the lab to the clinic, innovative gene synthesis technologies and gene editing tools have transformed basic, translational, and biomedical research. GenScript has partnered with pioneers pushing the boundaries in gene and cell engineering by providing its deep expertise in gene synthesis technologies. This first GenScript Gene & Cell Engineering Virtual Summit will showcase cutting-edge research from leaders leveraging synthetic biology technologies in drug-discovery, de novo protein design, and genome-editing.

The GenScript Gene & Cell Engineering Virtual Summit will feature a keynote presentation by Alexander Marson, MD, Ph.D., Director, Gladstone-UCSF Institute of Genomic Immunology. His webinar titled, Reprogramming Human T Cells with CRISPR, will discuss current approaches for CRISPR genome editing in primary human T cells, review progress toward clinical genome editing with non-viral knockin strategies, explore the application of genome-wide screens as discovery platform for enhanced cellular therapies.

For more about the GenScript Gene & Cell Engineering Virtual Summit, speakers, and agenda, and to register, click here.

*The event will remain open 12 months from the date of the live event. The webinars will be available for unlimited on-demand viewing.

About GenScript

GenScript is the leading contract research organization in the world providing gene, peptide, protein, CRISPR, and antibody. Since its foundation in 2002, GenScript has grown exponentially through partnerships with scientists conducting fundamental life science research, translational biomedical research, and early stage pharmaceutical development. The company is recognized as having built a best-in-class capacity and capability for biological research services, encompassing gene synthesis, peptide synthesis, custom antibody and protein engineering, and in vitro and in vivo pharmacology – all with the goal to Make Research Easy. For more information, visit www.genscript.com.

About Labroots

Labroots is the leading scientific social networking website, offering top scientific trending news and premier educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, Labroots is a powerful advocate in amplifying global networks and communities. Not registered yet as a Labroots user? Click here to sign up for free.

Avatar
admin@labroots.com
No Comments

Sorry, the comment form is closed at this time.